Skip to main content

Table 3 CAR-T cell therapy in clinical trials for head and neck cancers

From: A review on the advances and challenges of immunotherapy for head and neck cancer

Target Phase Sponsor Identifier
ErbB I/II King's College London NCT01818323
HER2 I Baylor College of Medicine NCT03740256
EpCAM I Sichuan University NCT02915445
NKG2D I CytoMed Therapeutics Pte Ltd NCT04107142
LMP1 I/II The Second Hospital of Nanjing Medical University NCT02980315
LMP1, LMP2, and EBNA1 II Fujian Cancer Hospital NCT03648697